|
||||||||||||||||||||
|
|
| Upcoming Programs | ||||||
|
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||
Overview
Atherothrombosis is the leading cause of death worldwide and the underlying process in the etiology of acute coronary syndrome (ACS), stroke and vascular death. Cardiovascular risk factors such as obesity, the metabolic syndrome, diabetes mellitus, hypertension, smoking and other "lifestyle" risks contribute to this pandemic of atherothrombotic disease. Patients with ACS, stroke/TIA and PAD (peripheral arterial disease), present major challenges to the primary care clinician in terms of managing CV risk factors and prevention of a second event. This lecture will overview current studies and treatment guidelines for PAD, ACS and Stroke and explore the role of primary care in long-term treatment of these patients.
Objectives
Describe 3 clinical conditions in which dual antiplatelet therapy is recommended
Name 5 treatment recommendations for reduction of global CV risk
Faculty
Martin W. Schwarze, DO, FACC
Clinical Professor of Medicine
St. Louis University School of Medicine
St. Louis, MO
Lawrence E. Mieczkowski, MD
Clinical Associate Professor of Medicine
Wright State University School of Medicine
Dayton, OH
Overview
Smoking is the single most important preventable cause of death in the United States. This session, "Do Ask, Do Tell: Successful Smoking Interventions", will address practical ways primary care clinicians can help their patients quit smoking.
Objectives
Screen all patients for smoking status and design individualized cessation interventions for patients who smoke
Commit to active follow-up with patients along the smoking cessation path
Faculty
Katherine Galluzzi, DO, CMD
Overview
Is hyperuricemia another door to the metabolic syndrome? This activity will focus on hyperuricemia and gout and will examine the latest guidance around treating patients in the primary care practice. The program will include a focus on the latest guidelines as well as applying the learning into everyday practice dynamics.
Objectives
List the key components of a differential diagnosis for gout based on clinical history and physical examination elements
Develop a treatment plan, which includes behavioral modification and pharmacologic strategies
Faculty
Peter A. Simkin, MD
Emeritus Professor of Medicine
University of Washington
American College of Rheumatology Master
Seattle, WA
Paul P. Doghramji, MD, FAAFP
Family Physician
Collegeville Family Practice
Medical Director of Health Services, Ursinus College
Collegeville, PA
Overview
This presentation will address early and aggressive LDL-C management and the clinical challenges of goal attainment. Clinicians will be provided with pathways and knowledge to help them improve their patient outcomes by goal attainment of the healthy lipid profile.
Discussion will be applicable to clinicians' practice including lifestyle changes of diet and exercise, along with pharmacologic treatment options available for lipid management in order to give the appropriate tools to get patients to their true LDL goals.
Objectives
Understand the key tenets of assessing and managing dyslipidemia in clinical practice and the current evidence regarding the safety and efficacy of available LDL-C lowering therapies
Identify at least 2 lipid lowering strategies to initiate and tailor comprehensive management treatment plans for patients with high LDL-C in order to reach and maintain targeted goals
Faculty
Emma Meagher, MD
Associate Professor
University of Pennsylvania, School of Medicine
Philadelphia, PA
John Russell, MD
Clinical Associate Professor of Family and Community Medicine
Temple University School of Medicine
Philadelphia, PA
Overview
This program will underscore the importance of osteoporosis screening, risk-benefit analysis, treatment selection, and long-term patient adherence. Evidence-based data on available and emerging pharmacotherapies will be presented to assist with treatment initiation, efficacy issues, and long-term safety assessment. Clinical challenges such as use and interpretation of BMD testing, patient adherence, and treatment failure will also be addressed.
Objectives
Assess for risk factors of osteoporosis to identify which patients require additional screening
Relate the application of available and emerging treatments for osteoporosis
Faculty
Christine Simonelli, MD
Associate Clinical Professor of Medicine
University of Minnesota
Director, Osteoporosis Care
HealthEast Clinics
St. Paul, MN
Overview
For some, alleviating a headache is as simple as taking two aspirin. But for the approximate 28 million Americans who suffer from migraine, this is not the case. In light of new research that has brought about this understanding, clinicians have also been able to implement new and individualized treatment strategies tailored specifically the needs and characteristics of the patient. This educational activity will provide an in-depth look at how primary care clinicians can obtain the best outcomes for their patients with migraine.
Objectives
Recognize migraine by using symptom-based criteria and headache calendars to recognize physiological and environmental triggers
Identify specific strategies that address the management of clinically identified migraine types
Faculty
Brian Koffman, MDCM
Clinical Professor, Department of Family Medicine
Keck School of Medicine, USC Family Practice
St. Jude Heritage Medical Group
Diamond Bar, CA